A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients - Related Studies

A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients

This study is not yet open for participant recruitment.

Study NCT00336310. Last updated on June 12, 2006. Information provided by National Cheng-Kung University Hospital

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Diabetes Mellitus, Type 2

2	Additional conditions recognized in this trial
		Diabetes Mellitus

3	More general conditions related to this trial
		Endocrine System Diseases
		Glucose Metabolism Disorders
		Metabolic Diseases

4	Interventions listed in this trial
		Repaglinide

5	More general drug interventions related to this trial
		Hypoglycemic Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

6	Sponsors listed in this trial
		National Cheng-Kung University Hospital